Benzinga's Top Initiations

Goldman Sachs initiated coverage on shares of Synageva BioPharma GEVA with a “buy” rating. The target price for Synageva BioPharma is set to $72. Synageva BioPharma's shares closed at $52.61 yesterday. Bank of America initiated coverage on shares of Prothena PRTA with a “neutral” rating. The target price for Prothena is set to $28. Prothena's shares closed at $27.09 yesterday. Analysts at Mizuho Securities initiated coverage on shares of Abercrombie & Fitch Company ANF with a “neutral” rating. Abercrombie & Fitch's shares closed at $35.16 yesterday. Analysts at DA Davidson initiated coverage on shares of Exterran Holdings EXH with a “neutral” rating. The target price for Exterran Holdings is set to $35. Exterran's shares closed at $32.78 yesterday.